Clinical Trial Update: A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma [Phase 4]

View source ↗

Summary

Clinical trial update shows a Phase 4 study to assess safety of Teclistamab in Indian participants with relapsed and refractory multiple myeloma, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: Johnson & Johnson Private Limited | Conditions: Multiple Myeloma | Phase 4 | Status: RECRUITING